These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 22202645)

  • 1. [What's new in internal medicine: emerging treatments for systemic lupus erythematosus].
    Hachulla É
    Ann Dermatol Venereol; 2011 Dec; 138 Suppl 4():S241-4. PubMed ID: 22202645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell targeted therapies in systemic lupus erythematosus: successes and challenges.
    Harvey PR; Gordon C
    BioDrugs; 2013 Apr; 27(2):85-95. PubMed ID: 23456653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologics in SLE: towards new approaches.
    van Vollenhoven RF; Parodis I; Levitsky A
    Best Pract Res Clin Rheumatol; 2013 Jun; 27(3):341-9. PubMed ID: 24238691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New treatment strategy including biological agents in patients with systemic lupus erythematosus.
    Leszczyński P; Pawlak-Buś K
    Pol Arch Med Wewn; 2013; 123(9):482-90. PubMed ID: 23828116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies.
    Dall'era M; Chakravarty EF
    Curr Rheumatol Rep; 2011 Aug; 13(4):308-16. PubMed ID: 21584692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When biologics should be used in systemic lupus erythematosus?
    Gottenberg JE; Lorenzo N; Sordet C; Theulin A; Chatelus E; Sibilia J
    Presse Med; 2014 Jun; 43(6 Pt 2):e181-5. PubMed ID: 24933678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the use of biologics in lupus.
    Relan M; Vishwanath S; Shen L; Ambrus JL
    Curr Pharm Biotechnol; 2014; 15(6):516-20. PubMed ID: 25091119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to treat refractory arthritis in lupus?
    Artifoni M; Puéchal X
    Joint Bone Spine; 2012 Jul; 79(4):347-50. PubMed ID: 22341583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New developments in the treatment of systemic lupus erythematosus.
    Tullus K
    Pediatr Nephrol; 2012 May; 27(5):727-32. PubMed ID: 21516516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of biologic therapies for systemic lupus erythematosus treatment: systematic review and meta-analysis.
    Borba HH; Wiens A; de Souza TT; Correr CJ; Pontarolo R
    BioDrugs; 2014 Apr; 28(2):211-28. PubMed ID: 24190520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell-targeted therapy for systemic lupus erythematosus.
    Sabahi R; Anolik JH
    Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic lupus erythematosus: an update on current pharmacotherapy and future directions.
    Touma Z; Urowitz MB; Gladman DD
    Expert Opin Biol Ther; 2013 May; 13(5):723-37. PubMed ID: 23339281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments in the treatment of patients with systemic lupus erythematosus: focusing on biologic therapies.
    Fattah Z; Isenberg DA
    Expert Opin Biol Ther; 2014 Mar; 14(3):311-26. PubMed ID: 24387632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol.
    Teng YKO; Bruce IN; Diamond B; Furie RA; van Vollenhoven RF; Gordon D; Groark J; Henderson RB; Oldham M; Tak PP
    BMJ Open; 2019 Mar; 9(3):e025687. PubMed ID: 30898822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there still a role for abatacept in the treatment of lupus?
    Hoi A; Littlejohn G
    Expert Opin Biol Ther; 2014 Sep; 14(9):1345-50. PubMed ID: 25005704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The management of systemic lupus erythematosus with biological therapies].
    Malaise O; von Frenckell C; André B; Malaise MG
    Rev Med Suisse; 2013 Aug; 9(395):1507-11. PubMed ID: 24024419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell-targeted therapy for systemic lupus erythematosus: an update.
    Ding C; Foote S; Jones G
    BioDrugs; 2008; 22(4):239-49. PubMed ID: 18611066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Allergo-immunology. Clinical immunology].
    Chizzolini C
    Rev Med Suisse; 2012 Jan; 8(323):11-3. PubMed ID: 22303732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and opportunities in SLE clinical trials.
    van Vollenhoven RF
    Curr Opin Rheumatol; 2013 Sep; 25(5):606-15. PubMed ID: 23917158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.